Atlas

Form 483

Wells Pharmacy, Inc Form 483, 2026-04-09

FDA issued a Form 483 to Wells Pharmacy, Inc on 2026-04-09 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Wells Pharmacy, Inc · Dyersburg, United States · Issued April 9, 2026

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Apr 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Demario L Walls

9 Apr 2026
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Demario L Walls

Inspected site

WPWells Pharmacy, IncDyersburg, United States

Inspection team

DLDemario L Walls

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere